SCHEMBL6705458

SCHEMBL6705458

C[SiH](C)C(C)(C)COc1ccc(Cl)c(CBr)c1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 1/20 0.35
GPR84 Q9NQS5 1/20 0.32
GAA P10253 1/20 0.32
MCL1 Q07820 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
HTT P42858 1/20 0.31
HTR2A P28223 4/20 0.31
SLC6A4 P31645 4/20 0.31
KCNH2 Q12809 3/20 0.31
PKM P14618 1/20 0.31
BCL2 P10415 1/20 0.30
P4HB P07237 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
NOS3 P29474 1/20 0.30
NOS1 P29475 1/20 0.30
NOS2 P35228 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoyl Peroxide SCHEMBL7510601 0.85 NR4A2 (0.37) L3MBTL1KDM4EALDH1A1MCL1BCL2
SCHEMBL3686690 0.84
SCHEMBL14992680 0.82 GPR84 (0.39) L3MBTL1KDM4EALDH1A1GPR84MCL1
SCHEMBL181183 0.76 HTR2A (0.41) HTR2ASLC6A4KCNH2
SCHEMBL2880031 0.73 PKM (0.40) L3MBTL1KDM4EMEN1KMT2AHTR2A
SCHEMBL2009535 0.73 KDM4E (0.33) L3MBTL1KDM4EKMT2A
SCHEMBL2880278 0.73 CYP1A2 (0.34) MEN1KMT2A
SCHEMBL16871893 0.73 SLC5A2 (0.37)
SCHEMBL474102 0.72 HTR2A (0.46) ALDH1A1MEN1KMT2AHTR2ASLC6A4
SCHEMBL661988 0.72 L3MBTL1 (0.47) L3MBTL1KDM4EALDH1A1GPR84GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058988-A1 FATTY ACID SYNTHASE INHIBITORS GLAXOSMITHKLINE LLC 2004-03-25 US disclosed
US-20030220392-A1 Fatty acid synthase inhibitors SMITHKLINE BEECHAM CORPORATION 2003-11-27 US disclosed
EP-1299376-A1 FATTY ACID SYNTHASE INHIBITORS Smithkline Beecham (US) 2003-04-09 EP disclosed
US-6498187-B1 SUCH AS 2'-(6-CHLOROPIPERONYL)-3-(2,6-DICHLOROBENZYLOXY)-CINNAMIC ACID; ANTIBIOTICS SMITHKLINE BEECHAM CORPORATION 2002-12-24 US disclosed
WO-2001090099-A1 FATTY ACID SYNTHASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220392-A1 Fatty acid synthase inhibitors FASN, FADS1, FADS2 L3MBTL1 3206/4885KDM4E 2316/4885ALDH1A1 985/4885
US-20040058988-A1 FATTY ACID SYNTHASE INHIBITORS FASN, FADS1, FADS2 L3MBTL1 3206/4885KDM4E 2316/4885ALDH1A1 985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.